Was it $24m in sales, or net profit on Qbrexza?
As can be seen below, Euroz Hartleys are suggesting BOT's SB net sales in 2025 of $175m, but due to royalties, milestones, costs and tax - an after tax profit of only $22m. Could that be a similar scenario for Eli Lilly and their purchase of Qbrexza maybe?
Was it $24m in sales, or net profit on Qbrexza?As can be seen...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 35.5¢ | $1.465M | 4.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 186321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 561591 | 7 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |